LSTA

NASDAQ 已收盘

Lisata Therapeutics

0.90 USD
▼-0.01-1.22%
盘后 0.88 -2.10%
2026-11-20
市值
$8.10M
市盈率
—
EPS
-1.89
股息率
—
52 周区间
0.85 – 5.07
成交量
139.26K
Beta
1.02
目标价
4.00
52W 低 0.8552W 高 5.07
价格走势

公司简介

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as C...